We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
+30.37%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$14.5B
AUM Growth
+$2.88B
Cap. Flow
-$198M
Cap. Flow %
-1.37%
Top 10 Hldgs %
16.33%
Holding
1,216
New
16
Increased
105
Reduced
134
Closed
10

Top Buys

Rank Stock Value
1
MD icon
Pediatrix Medical
MD
+$111M
2
AROC icon
Archrock
AROC
+$56.8M
3
CBRL icon
Cracker Barrel
CBRL
+$46.8M
4
SABR icon
Sabre
SABR
+$46.5M
5
CNMD icon
CONMED
CNMD
+$43.5M

Sector Composition

Rank Sector Weight
1 Technology 20.53%
2 Financials 17.45%
3 Industrials 16.51%
4 Healthcare 12.3%
5 Consumer Discretionary 10.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
151
UnitedHealth
UNH
$382B
$19.3M 0.13%
54,947
-21,093
-28% -$7.07M
DIS icon
152
Walt Disney
DIS
$171B
$19.1M 0.13%
105,589
-54,399
-34% -$7.81M
AYI icon
153
Acuity Brands
AYI
$9.99B
$18.8M 0.13%
155,177
-11,162
-7% -$1.2M
UNP icon
154
Union Pacific
UNP
$174B
$18.4M 0.13%
88,541
-41,040
-32% -$8.2M
CLR
155
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$17.9M 0.12%
1,095,841
-269,862
-20% -$4.03M
MS icon
156
Morgan Stanley
MS
$319B
$17.5M 0.12%
254,863
-139,186
-35% -$7.99M
GD icon
157
General Dynamics
GD
$103B
$17.4M 0.12%
117,138
-38,983
-25% -$5.7M
ITUB icon
158
Itaú Unibanco
ITUB
$89.8B
$15.3M 0.11%
3,448,737
-1,596,878
-32% -$5.97M
MUR icon
159
Murphy Oil
MUR
$5.55B
$14.2M 0.1%
1,177,406
+84,981
+8% +$844K
FANG icon
160
Diamondback Energy
FANG
$56B
$14.1M 0.1%
292,286
+55,509
+23% +$2.05M
ELV icon
161
Elevance Health
ELV
$81.5B
$14.1M 0.1%
43,867
-33,907
-44% -$10.4M
MPT
162
Medical Properties Trust
MPT
$2.84B
$13.7M 0.09%
628,950
-657,446
-51% -$12.8M
EC icon
163
Ecopetrol
EC
$33.7B
$13.4M 0.09%
1,039,357
+15,159
+1% +$171K
DE icon
164
Deere & Co
DE
$165B
$13.4M 0.09%
49,649
+238
+0.5% +$59.1K
TTGT icon
165
TechTarget
TTGT
$327M
$12.8M 0.09%
216,520
-20,858
-9% -$1.08M
JPM icon
166
JPMorgan Chase
JPM
$916B
$12.4M 0.09%
97,861
-60,896
-38% -$6.81M
SLB icon
167
SLB Ltd
SLB
$72.7B
$11.8M 0.08%
542,588
-174,844
-24% -$3.3M
GS icon
168
Goldman Sachs
GS
$289B
$11M 0.08%
41,845
-24,338
-37% -$5.42M
IWN icon
169
iShares Russell 2000 Value ETF
IWN
$14.3B
$6.88M 0.05%
52,237
+51,286
+5,393% +$6.05M
ERIC icon
170
Ericsson
ERIC
$32.1B
$6.59M 0.05%
551,526
+410,606
+291% +$4.81M
ESS icon
171
Essex Property Trust
ESS
$19.1B
$6.58M 0.05%
27,718
+162
+0.6% +$37.4K
NTRS icon
172
Northern Trust
NTRS
$21.8B
$6.18M 0.04%
66,368
-54,681
-45% -$4.82M
RCL icon
173
Royal Caribbean
RCL
$86.5B
$5.96M 0.04%
79,848
-79,047
-50% -$5.51M
BMTC
174
DELISTED
Bryn Mawr Bank Corp
BMTC
$5.91M 0.04%
193,165
+7,672
+4% +$224K
FBK icon
175
FB Financial Corp
FBK
$2.98B
$5.68M 0.04%
163,546
-7,375
-4% -$232K

Similar funds

EARNEST Partners's Q4 2020 Portfolio in Review

As of Q4 2020, EARNEST Partners held 1,216 positions worth $14.5B, up 25% from $11.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2020: portfolio turnover was 2.1%. EARNEST Partners opened 16 new positions and exited 10, leaving the 1,216-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Industrials.

  • EARNEST Partners's largest Q4 2020 buy was TTM Technologies: 400,909 shares worth $5.53M.
  • EARNEST Partners added most to Pediatrix Medical in Q4 2020, an estimated $111M increase.
  • EARNEST Partners's biggest Q4 2020 reduction was American Equity Investment Life Holding Company, cutting an estimated $94.4M.
  • EARNEST Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $10K.
  • EARNEST Partners's ten largest holdings make up 16% of its $14.5B portfolio in Q4 2020.
  • EARNEST Partners opened 16 new positions and closed 10 in Q4 2020.
  • EARNEST Partners's portfolio value rose 25% quarter-over-quarter to $14.5B.

Based on EARNEST Partners's 13F filing for Q4 2020, filed 16 Feb 2021.